Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg von Krogh

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|March 15, 2011
Clusters in the biopharmaceutical industry: toward a new method of analysisZeynep Erden, Georg von Krogh
Organization Studies|June 20, 2022
Expertise Diversity, Informal Leadership Hierarchy, and Team Knowledge Creation: A study of pharmaceutical research collaborationsVivianna Fang He, Georg von Krogh, Charlotta Sirén
Nature Computational Science|January 4, 2024
Building open-source AIYash Raj Shrestha, Georg von Krogh, Stefan Feuerriegel
Plos One|March 13, 2024
"The double-edged sword of inflated help": Unravelling the motivation crowding in community question-answering platformsVaibhav Krishna, Yash Raj Shrestha, Georg von Krogh
Nature Biotechnology|October 12, 2012
The changing face of corporate venturing in biotechnologyGeorg von Krogh, Boris Battistini, Fotini Pachidou, et al.
Drug Discovery Today|May 7, 2009
Strategic groups in the biopharmaceutical industry: implications for performanceZeynep Erden, Georg von Krogh, Cecilia Nytorp, et al.
Organization Studies|January 9, 2023
Openness as Organizing Principle: Introduction to the Special IssueVioletta Splitter, Leonhard Dobusch, Georg von Krogh, et al.
Drug Discovery Today|June 19, 2012
Rethinking leadership in drug discovery projectsAndreas Schneider, Zeynep Erden, Hans Widmer, et al.
Nature Biomedical Engineering|March 24, 2020
How the new European regulation on medical devices will affect innovationShiko M Ben-Menahem, Raymond Nistor-Gallo, Gloria Macia, et al.
BMJ Open|November 23, 2021
How do healthcare providers construe patient complexity? A qualitative study of multimorbidity in HIV outpatient clinical practiceShiko Ben-Menahem, Anastassja Sialm, Anna Hachfeld, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|March 15, 2011
Clusters in the biopharmaceutical industry: toward a new method of analysisZeynep Erden, Georg von Krogh
Organization Studies|June 20, 2022
Expertise Diversity, Informal Leadership Hierarchy, and Team Knowledge Creation: A study of pharmaceutical research collaborationsVivianna Fang He, Georg von Krogh, Charlotta Sirén
Nature Computational Science|January 4, 2024
Building open-source AIYash Raj Shrestha, Georg von Krogh, Stefan Feuerriegel
Plos One|March 13, 2024
"The double-edged sword of inflated help": Unravelling the motivation crowding in community question-answering platformsVaibhav Krishna, Yash Raj Shrestha, Georg von Krogh
Nature Biotechnology|October 12, 2012
The changing face of corporate venturing in biotechnologyGeorg von Krogh, Boris Battistini, Fotini Pachidou, et al.
Drug Discovery Today|May 7, 2009
Strategic groups in the biopharmaceutical industry: implications for performanceZeynep Erden, Georg von Krogh, Cecilia Nytorp, et al.
Organization Studies|January 9, 2023
Openness as Organizing Principle: Introduction to the Special IssueVioletta Splitter, Leonhard Dobusch, Georg von Krogh, et al.
Drug Discovery Today|June 19, 2012
Rethinking leadership in drug discovery projectsAndreas Schneider, Zeynep Erden, Hans Widmer, et al.
Nature Biomedical Engineering|March 24, 2020
How the new European regulation on medical devices will affect innovationShiko M Ben-Menahem, Raymond Nistor-Gallo, Gloria Macia, et al.
BMJ Open|November 23, 2021
How do healthcare providers construe patient complexity? A qualitative study of multimorbidity in HIV outpatient clinical practiceShiko Ben-Menahem, Anastassja Sialm, Anna Hachfeld, et al.
Pageof 2